Search This Blog

Tuesday, July 23, 2019

Dr. Reddy’s launches generic Rozerem sleep aid tablets in U.S.

Dr. Reddy’s Laboratories (RDY -2%announces the commercial launch of its Ramelteon Tablets, 8 mg, the generic equivalent of Takeda’s (TAK +0.5%) sleep aid Rozerem (ramelteon) 8 mg tablets.
Per IQVIA, the U.S. market is ~$91M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.